ÂÜÀòÂÒÂ×

Paul Weil is an experienced professional in the pharmaceutical industry with a strong background in market access. With their tenure at Avadel Pharmaceuticals plc, Greenwich Biosciences, Avanir Pharmaceuticals, Amylin Pharmaceuticals, Schering-Plough, and Eli Lilly and Company, Paul has held various senior positions focusing on maximizing reimbursement and business opportunities within managed care, wholesale, and retail national accounts. Paul Weil's expertise lies in designing and implementing business plans, contracting strategies, and pull-through initiatives to achieve sales and corporate goals. Paul holds a BS in Business from the University of Delaware.